Crescent Medicaments Private Limited
About Crescent Medicaments Private Limited
Data last updated:
Crescent Medicaments Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 05 June 2017 and has been in existence for over 9 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24304TG2017PTC117548. Its GSTIN is 36AAECI5222K1ZK (Telangana). The company holds 2 GST registrations, all of them active.
The company has an authorised share capital of ₹50 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Shaik Janimiya (Managing Director) and Javeed Shaik (Whole-Time Director).
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Crescent Towers 4 – 7 – 11/4/C Raghavendra Ngr Nacharam, Hyderabad, Telangana, India – 500076.
As per the financials filed for FY 2025, the company reported a revenue of ₹53,900. For the same year it recorded a net loss of ₹60,898 (net margin -113%) and EBITDA of -₹60,107 (EBITDA margin -111.5%). Revenue has declined at a compounded annual rate (CAGR) of 90% over three years and 75% over five years.
The company has about 31 employees on its provident fund (EPFO) records.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Crescent Medicaments Private Limited's registered office is in Hyderabad, Telangana. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressCrescent Towers 4 – 7 – 11/4/C Raghavendra Ngr Nacharam, Hyderabad, Telangana, India – 500076
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Crescent Medicaments Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Crescent Medicaments Private Limited
FY 2025 filings availableCrescent Medicaments Private Limited reported revenue of ₹53,900 for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 75% over five years. EBITDA fell 79% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹60,107 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹60,898 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -111.5% | ||||
| Net Profit Margin | -113% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Crescent Medicaments Private Limited, buy the company report.
Board of directors of Crescent Medicaments Private Limited
Crescent Medicaments has 4 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Javeed Shaik | Whole-Time Director | 05 Jun 2017 | 9 Years 4 Months | Current |
| Shaik Junaid | Director | 18 Jan 2021 | 5 Years 9 Months | Current |
| Shaik Janimiya | Managing Director | 05 Jun 2017 | 9 Years 4 Months | Current |
| Shaik Thahera | Whole-Time Director | 05 Jun 2017 | 9 Years 4 Months | Current |
Auditor
Crescent Medicaments Private Limited is audited by S.N.M. Nandury & Co for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| S.N.M. Nandury & Co | FY 2023 | 201040 |
Shareholding
The shareholding of Crescent Medicaments Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Crescent Medicaments Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Crescent Medicaments Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Crescent Medicaments Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Crescent Medicaments has 2 GST registrations: 2 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AAECI5222K1ZK | Telangana | Active | 06 Apr 2018 |
| 37AAECI5222K1ZI | Andhra Pradesh | Active | 12 Apr 2018 |
To see the full GST registrations and return filing status of Crescent Medicaments Private Limited, buy the company report.
Recent activity
Crescent Medicaments Private Limited has 4 board changes on record since 2017: 4 appointments. The latest: Shaik Junaid was appointed as Director on 18 Jan 2021.
Frequently asked questions
Crescent Medicaments is an active private limited company based in Hyderabad, Telangana, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 05 June 2017 (9+ years old) and is registered under CIN U24304TG2017PTC117548.
Crescent Medicaments has 4 current directors:
- Shaik Janimiya - Managing Director
- Javeed Shaik - Whole-Time Director
- Shaik Thahera - Whole-Time Director
- Shaik Junaid - Director
The latest financial statements of Crescent Medicaments on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2018 are in the company report.
The GSTIN of Crescent Medicaments is 36AAECI5222K1ZK, registered in Telangana. The company has 2 GST registrations in all, of which 2 are active. Other active GSTINs include 37AAECI5222K1ZI (Andhra Pradesh).
The CIN (Corporate Identification Number) of Crescent Medicaments is U24304TG2017PTC117548. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Crescent Medicaments was incorporated on 05 June 2017, making it 9+ years old. It is registered with the Registrar of Companies, Hyderabad.
Shaik Junaid was appointed as Director on 18 Jan 2021. Javeed Shaik was appointed as Whole-Time Director on 05 Jun 2017. Shaik Janimiya was appointed as Managing Director on 05 Jun 2017. Crescent Medicaments has 4 board changes on record in total.
The registered office of Crescent Medicaments is at Crescent Towers 4 – 7 – 114C Raghavendra Ngr Nacharam, Hyderabad, Telangana, India – 500076.
Crescent Medicaments operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
The compliance status of Crescent Medicaments is compliant as of 18 July 2026. The company is actively filing with the Registrar of Companies.